csl must be taking so much market share. is why they do so much research spending to almost try hide the enormously profitable market position they inhabit.
News: CSL CSL's Privigen Granted Orphan-Drug Designation For The Investigational Treatment Of..., page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$277.77 |
Change
2.270(0.82%) |
Mkt cap ! $133.8B | |||
| Open | High | Low | Value | Volume |
| $277.50 | $278.05 | $276.24 | $65.92M | 238.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 67 | $277.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $277.79 | 36 | 1 |
View Market Depth
| Last trade - 13.18pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$277.91 |
Change
2.270 ( 0.88 %) |
||||
| Open | High | Low | Volume | ||
| $277.13 | $278.05 | $276.25 | 18379 | ||
| Last updated 13.36pm 07/05/2024 ? | |||||
| CSL (ASX) Chart |